IDEAYA Biosciences initiates Phase 1/2 monotherapy expansion for IDE892 in solid tumors
IDEAYA Biosciences (NASDAQ:IDYA) announced the initiation of the Part 2 monotherapy expansion for its Phase 1/2 clinical trial evaluating IDE892.
IDEAYA Biosciences (NASDAQ:IDYA) announced the initiation of the Part 2 monotherapy expansion for its Phase 1/2 clinical trial evaluating IDE892.
AstraZeneca (NYSE:AZN) reported second-quarter core EPS of $2.63, up 21%, as oncology and rare-disease sales grew.
Nvidia is in discussions to provide a financing guarantee to help OpenAI lease a $500 billion, 10-gigawatt hub that SoftBank Group is overseeing in Ohio, people familiar with the matter said. Peter Elstrom reports on Bloomberg Television.
Plurimi Wealth CIO Patrick Armstrong discusses market moves as oil prices dropped after the US paused almost two weeks of daily strikes against Iran. "Even if we do get a relatively open Strait of Hormuz, it is going to be a restocking phase that'll support oil prices," Armstrong tells Bloomberg Television. He adds that oil around $90 a barrel is "a headwind for growth but not terribly so," but should prices go higher, it puts central banks in a "very difficult position."
The9 (NASDAQ:NCTY) reported its first-quarter 2026 financial results, generating an unaudited net income of $23 million for the period ended March 31, 2026.
argenx (NASDAQ:ARGX) agreed to acquire Forte Biosciences (NASDAQ:FBRX) for $77 per share, valuing the company at $2.2 billion.
TotalEnergies (NYSE:TTE) will appeal a court order requiring Scope 3 climate risks in its vigilance plan within six months.
AstraZeneca Chief Financial Officer Aradhana Sarin says the company is "very much on track" to reach its $80 billion sales target by 2030. "From a pharma standpoint, we are probably one of the most diversified from a product and pipeline, as well as probably the most diversified geographically," Sarin says. She speaks on Bloomberg Television as the company reported higher-than-expected profit, buoyed by blockbuster cancer medicines.
Anna Edwards, Guy Johnson and Skylar Montgomery Koning break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."
AI is changing the game for regional consulting amid geopolitical uncertainty and rising competition between major economies. Tamer Charife, Technology and Transformation Growth Leader at Deloitte Middle East spoke to Bloomberg's Abeer Abu Omar on Horizons Middle East and Africa on the data center investments & AI push in the region.
Brown University Professor of Practice, Yamini Aiyar, argues that the Indian Education Minister's resignation might not be enough to calm youth anger. Aiyar says the protests exposed a deeper crisis facing India's youth. She spoke with Paul Allen on Bloomberg's Insight with Haslinda Amin.
Brown University Professor of Practice, Yamini Aiyar, argues that the Indian Education Minister's resignation might not be enough to calm youth anger. Aiyar says the protests exposed a deeper crisis facing India's youth. She spoke with Paul Allen on Bloomberg's Insight with Haslinda Amin.